Candel Therapeutics, Inc. (CADL)

Candel Therapeutics, Inc. (CADL) stock — financials & valuation

Key numbers for Candel Therapeutics, Inc. (CADL): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 35/100 — a percentile rank of Candel Therapeutics, Inc.’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.

Is Candel Therapeutics, Inc. overvalued? P/B looks overvalued vs its 5-year range.

Independent of the events above — derived from Candel Therapeutics, Inc.’s own financial statements and shown as context, never as advice.